Condition
Eradication
Total Trials
5
Recruiting
0
Active
0
Completed
3
Success Rate
100.0%+14% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
40%
2 trials in Phase 3/4
Results Transparency
0%
0 of 3 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
4Total
P 1 (2)
P 4 (2)
Trial Status
Completed3
Unknown2
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT06823791Phase 1Completed
Furazolidone Quadruple Regimen Eradicate H. Pylori Infection
NCT05586464Phase 1Unknown
Eradication of Helicobacter Pylori With Bismuth Agent Quadruple and Traditional Chinese Medicine
NCT00596401Completed
The Preventive Effect of Helicobacter Pylori Eradication on the Development of Gastric Cancer
NCT04618159Phase 4CompletedPrimary
Does Helipyl Eradicate
NCT02934048Phase 4Unknown
Optimal Duration of Antimicrobial Susceptibility Test (AST) Guided Rescue Therapy for Helicobacter Pylori Infection
Showing all 5 trials